Osaic Holdings
VBIO

Osaic Holdings’s Valion Bio VBIO Stock Holding History

Osaic Holdings’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8
Closed -$35 – 7625
2024
Q3 		$35 Sell
8
-1
-11% -$6 ﹤0.01% 7316
2024
Q2 		$55 Hold
9
– – ﹤0.01% 7297
2024
Q1 		$182 Hold
9
– – ﹤0.01% 6968
2023
Q4 		$262 Hold
9
– – ﹤0.01% 6993
2023
Q3 		$251 Buy
9
+4
+80% +$296 ﹤0.01% 7111
2023
Q2 		$941 Sell
5
-4
-44% -$857 ﹤0.01% 6891
2023
Q1 		$2.2K Hold
9
– – ﹤0.01% 6673
2022
Q4 		$9K Buy
9
+4
+80% +$8.98K ﹤0.01% 6009
2022
Q3 		$13K Hold
5
– – ﹤0.01% 5885
2022
Q2 		$17K Hold
5
– – ﹤0.01% 5734
2022
Q1 		$14K Hold
5
– – ﹤0.01% 5949
2021
Q4 		$35K Buy
+5
New +$36.7K ﹤0.01% 5418

Other funds holding VBIO

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings's VBIO Position: Q4 2024 in Review

Osaic Holdings sold out of Valion Bio (VBIO) in Q4 2024, closing a stake of 8 shares — an estimated $35 sold.

Osaic Holdings first reported a position in VBIO in Q4 2021 and held it in 12 quarters. The position peaked at $35K in Q4 2021. 9 funds tracked by Wall St. Rank hold VBIO as of Q4 2024.

  • Osaic Holdings reported no remaining Valion Bio position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 8 Valion Bio shares in Q4 2024, an estimated $35.
  • Osaic Holdings first reported a position in Valion Bio in Q4 2021 and held it in 12 quarters.
  • Osaic Holdings's Valion Bio position peaked at $35K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.